Literature DB >> 11861846

In vivo interference of Rous sarcoma virus budding by cis expression of a WW domain.

Akash Patnaik1, John W Wills.   

Abstract

For all enveloped viruses, the actual mechanism by which nascent virus particles separate or "pinch off" from the cell surface is largely unknown. In the case of retroviruses, the Gag protein drives the budding process, and the virus release step is directed by the late (L) assembly domain within Gag. A PPPPY motif within the L domain of Rous sarcoma virus (RSV) was previously characterized as being critical for the release of virions and shown to interact in vitro with the WW domain of Yes-associated protein (Yap). To determine whether WW domain-L domain interactions can occur in vivo, we attempted to interfere with the host cell machinery normally recruited to the site of budding by inserting this WW domain in different locations within Gag. At a C-terminal location, the WW(Yap) domain had no effect on budding, suggesting that the intervening I domains (which provide the major region of Gag-Gag interaction) prevent its access to the L domain. When positioned on the other side of the I domains closer to the L domain, the WW(Yap) domain resulted in a dramatic interference of particle release, and confocal microscopy revealed a block to budding on the plasma membrane. Budding was restored by attachment of the heterologous L domain of human immunodeficiency virus type 1 Gag, which does not bind WW(Yap). These findings suggest that cis expression of WW domains can interfere with RSV particle release in vivo via specific, high-affinity interactions at the site of assembly on the plasma membrane, thus preventing host factor accessibility to the L domain and subsequent virus-cell separation. In addition, they suggest that L domain-specific host factors function after Gag proteins begin to interact.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861846      PMCID: PMC135952          DOI: 10.1128/jvi.76.6.2789-2795.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Characterization of the WW domain of human yes-associated protein and its polyproline-containing ligands.

Authors:  H I Chen; A Einbond; S J Kwak; H Linn; E Koepf; S Peterson; J W Kelly; M Sudol
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

Review 2.  Characterization of a novel protein-binding module--the WW domain.

Authors:  M Sudol; H I Chen; C Bougeret; A Einbond; P Bork
Journal:  FEBS Lett       Date:  1995-08-01       Impact factor: 4.124

3.  WW domains and retrovirus budding.

Authors:  L Garnier; J W Wills; M F Verderame; M Sudol
Journal:  Nature       Date:  1996-06-27       Impact factor: 49.962

4.  An assembly domain of the Rous sarcoma virus Gag protein required late in budding.

Authors:  J W Wills; C E Cameron; C B Wilson; Y Xiang; R P Bennett; J Leis
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

5.  Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain.

Authors:  Y Xiang; C E Cameron; J W Wills; J Leis
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Identification of novel human WW domain-containing proteins by cloning of ligand targets.

Authors:  G Pirozzi; S J McConnell; A J Uveges; J M Carter; A B Sparks; B K Kay; D M Fowlkes
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

7.  Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide.

Authors:  M J Macias; M Hyvönen; E Baraldi; J Schultz; M Sudol; M Saraste; H Oschkinat
Journal:  Nature       Date:  1996-08-15       Impact factor: 49.962

8.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.

Authors:  M Huang; J M Orenstein; M A Martin; E O Freed
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins.

Authors:  R P Bennett; T D Nelle; J W Wills
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

10.  Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins.

Authors:  L J Parent; R P Bennett; R C Craven; T D Nelle; N K Krishna; J B Bowzard; C B Wilson; B A Puffer; R C Montelaro; J W Wills
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more
  14 in total

1.  Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4.

Authors:  Jillian M Licata; Martha Simpson-Holley; Nathan T Wright; Ziying Han; Jason Paragas; Ronald N Harty
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

2.  YRKL sequence of influenza virus M1 functions as the L domain motif and interacts with VPS28 and Cdc42.

Authors:  Eric Ka-Wai Hui; Subrata Barman; Dominic Ho-Ping Tang; Bryan France; Debi P Nayak
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

3.  ERV3 and related sequences in humans: structure and RNA expression.

Authors:  Ann-Catrin Andersson; Zhihong Yun; Göran O Sperber; Erik Larsson; Jonas Blomberg
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1.

Authors:  David E Ott; Lori V Coren; Tracy D Gagliardi; Kunio Nagashima
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 5.  WWP1: a versatile ubiquitin E3 ligase in signaling and diseases.

Authors:  Xu Zhi; Ceshi Chen
Journal:  Cell Mol Life Sci       Date:  2011-11-04       Impact factor: 9.261

6.  Basic residues of the helix six domain of influenza virus M1 involved in nuclear translocation of M1 can be replaced by PTAP and YPDL late assembly domain motifs.

Authors:  Eric Ka-Wai Hui; Subrata Barman; Tae Yong Yang; Debi P Nayak
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

7.  Molecular basis of the binding of YAP transcriptional regulator to the ErbB4 receptor tyrosine kinase.

Authors:  Brett J Schuchardt; Vikas Bhat; David C Mikles; Caleb B McDonald; Marius Sudol; Amjad Farooq
Journal:  Biochimie       Date:  2014-01-25       Impact factor: 4.079

Review 8.  No exit: targeting the budding process to inhibit filovirus replication.

Authors:  Ronald N Harty
Journal:  Antiviral Res       Date:  2008-12-27       Impact factor: 5.970

9.  Molecular origin of the binding of WWOX tumor suppressor to ErbB4 receptor tyrosine kinase.

Authors:  Brett J Schuchardt; Vikas Bhat; David C Mikles; Caleb B McDonald; Marius Sudol; Amjad Farooq
Journal:  Biochemistry       Date:  2013-12-13       Impact factor: 3.162

10.  PPPYVEPTAP motif is the late domain of human T-cell leukemia virus type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101 [corrected].

Authors:  Fadila Bouamr; Jessica A Melillo; Margaret Q Wang; Kunio Nagashima; Martha de Los Santos; Alan Rein; Stephen P Goff
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.